본문 바로가기

Prognostic Value of A/T/N Biomarkers: Comparing Plasma and Imaging Modalities in Alzheimer Disease

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q1Scopus Q3
저널
CLINICAL NUCLEAR MEDICINE50(12) · pp.1120 · 2025
피인용
Web of Science 2Scopus 1
FWCI (Scopus)
0.37
JCR IF
JCR 2024 9.6
ISSN
0363-9762

저자

  1. Yim, Sohyun제1저자Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, 81 Irwon Ro, Seoul 06351, South Korea
  2. Gu, YunaSungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, 81 Irwon Ro, Seoul 06351, South Korea
  3. Kang, HeekyungSungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, 81 Irwon Ro, Seoul 06351, South Korea
  4. Shin, DaeunSungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, 81 Irwon Ro, Seoul 06351, South Korea
  5. Jang, HyeminSeoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Neurol, Seoul, South Korea
  6. Yoo, HeejinSungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, 81 Irwon Ro, Seoul 06351, South Korea
  7. Zetterberg, HenrikUniv Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden
  8. Blennow, KajUniv Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden
  9. Gonzalez-Ortiz, FernandoUniv Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden
  10. Ashton, Nicholas J.Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Gothenburg, Sweden
  11. Weiner, Michael W.Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA USA
  12. Day, Theresa A.Eli Lilly & Co, Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN USA
  13. Lee, Eun HyeSungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, 81 Irwon Ro, Seoul 06351, South Korea
  14. Na, Duk L.Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, 81 Irwon Ro, Seoul 06351, South Korea
  15. Kim, Hee JinSungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, 81 Irwon Ro, Seoul 06351, South Korea
  16. Kang, Sung HoonKorea Univ, Guro Hosp, Coll Med, Dept Neurol, Seoul, South Korea
  17. Kim, Ko WoonJeonbuk Natl Univ, Med Sch & Hosp, Dept Neurol, Jeonju, South Korea
  18. Kim, Yeo JinHallym Univ, Coll Med, Kangdong Sacred Heart Hosp, Dept Neurol, Seoul, South Korea
  19. Kim, YeshinKangwon Natl Univ, Kangwon Natl Univ Hosp, Sch Med, Dept Neurol, Chunchon, South Korea
  20. Kim, JaehoHallym Univ, Coll Med, Dongtan Sacred Heart Hosp, Dept Neurol, Hwaseong, South Korea
  21. Chun, Min YoungYonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea
  22. 정나연Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Dept Neurol, Yangsan, South Korea
  23. Cho, Soo HyunChonnam Natl Univ, Chonnam Natl Univ Hosp, Med Sch, Dept Neurol, Gwangju, South Korea
  24. Kim, Jun PyoSungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, 81 Irwon Ro, Seoul 06351, South Korea
  25. Yun, Jihwan교신저자Kyung Hee Univ, Coll Med, Kyung Hee Univ Hosp, Dept Neurol, Seoul, South Korea
  26. Seo, Sang Won교신저자Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurol, 81 Irwon Ro, Seoul 06351, South Korea

초록

Background: Alzheimer disease (AD) is characterized by amyloid-β plaques (A), tau tangles (T), and neurodegeneration (N), collectively defining the ATN framework. While imaging biomarkers are well-established, the prognostic value of plasma biomarkers in predicting cognitive decline remains underexplored. This study compares plasma and imaging A/T/N biomarkers in predicting cognitive decline and evaluate the impact of combining biomarkers across modalities. Patients and Methods: We conducted a longitudinal study using K-ROAD cohort participants who underwent at least 2 cognitive assessments. All participants had plasma biomarker testing (Aβ ratio, p-tau181, p-tau231, p-tau217, NfL), and a subset with imaging biomarker assessments (Aβ PET, tau PET, structural MRI) formed an imaging subcohort. Multiple linear regression models identified the most predictive markers within each modality and evaluated the effect of combining A/T/N biomarkers. Results: Among 1,614 plasma cohort and 130 imaging subcohort participants, tau markers demonstrated the strongest predictive value. p-tau217MSDoutperforming other plasma biomarkers, and the neo-temporal ROI showing the highest predictive power among imaging biomarkers. In plasma-based model, adding neurodegeneration markers to combination of amyloid and tau biomarkers improved the performance. In imaging-based models, same strategy decreased the performance, suggesting that combinations of amyloid and tau PET captures the most relevant prognostic information. Conclusions: Imaging biomarkers, particularly tau PET, show superior prognostic accuracy compared with plasma biomarkers, whereas plasma biomarkers offer advantages in combination models through neurodegeneration markers. These findings underscore the complementary roles of plasma and imaging biomarkers and emphasize the need for tailored strategies for prognostic modeling in AD.

키워드

alzheimer diseaseATN frameworkimaging biomarkersplasma biomarkersprediction of cognitive declineprognostic modeling

식별자

Scopus EID
2-s2.0-105015395131
WoS UID
001616204300002